Ovarian Cancer Clinical Trial

Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Summary

The purpose of this study is evaluate whether a prehabilitation program is feasible and useful for women with advanced ovarian cancer receiving chemotherapy in preparation for debulking surgery.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma)
All subjects must be enrolled within 90 days of diagnosis
No prior treatment for ovarian carcinoma
All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon
Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan
Proficiency in English in the determination of the investigators of by patient self-report

Exclusion Criteria:

Patient under age 18
Prior treatment for ovarian cancer
Second opinion visit only
Immediate surgery plan without neoadjuvant treatment
No intended surgical plan
Chemotherapy administration exclusively planned at MSKCC regional site
Patient unwilling to sign consent

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

22

Study ID:

NCT04204811

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

22

Study ID:

NCT04204811

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.